| Year |
Citation |
Score |
| 2024 |
Clarke MA, Wentzensen N, Perkins RB, Garcia F, Arrindell D, Chelmow D, Cheung LC, Darragh TM, Egemen D, Guido R, Huh W, Locke A, Lorey TS, Nayar R, Risley C, et al. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus. Journal of Lower Genital Tract Disease. PMID 38446575 DOI: 10.1097/LGT.0000000000000802 |
0.379 |
|
| 2024 |
Wentzensen N, Garcia F, Clarke MA, Massad LS, Cheung LC, Egemen D, Guido R, Huh W, Saslow D, Smith RA, Unger ER, Perkins RB. Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process. Journal of Lower Genital Tract Disease. PMID 38446573 DOI: 10.1097/LGT.0000000000000804 |
0.342 |
|
| 2024 |
Befano B, Wentzensen N, Lorey T, Poitras N, Cheung LC, Schiffman M, Clarke MA, Cohen C, Kinney W, Locke A, Castle PE. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California. Gynecologic Oncology. 184: 89-95. PMID 38301311 DOI: 10.1016/j.ygyno.2024.01.038 |
0.455 |
|
| 2024 |
Stier EA, Clarke MA, Deshmukh AA, Wentzensen N, Liu Y, Poynten IM, Cavallari EN, Fink V, Barroso LF, Clifford GM, Cuming T, Goldstone SE, Hillman RJ, Rosa-Cunha I, La Rosa L, et al. International Anal Neoplasia Society's consensus guidelines for anal cancer screening. International Journal of Cancer. PMID 38297406 DOI: 10.1002/ijc.34850 |
0.389 |
|
| 2024 |
Desai KT, Hansen N, Rodriguez AC, Befano B, Egemen D, Gage JC, Wentzensen N, Lopez C, Jeronimo J, de Sanjose S, Schiffman M. Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs. Preventive Medicine. 180: 107881. PMID 38286273 DOI: 10.1016/j.ypmed.2024.107881 |
0.333 |
|
| 2024 |
de Sanjosé S, Perkins RB, Campos N, Inturrisi F, Egemen D, Befano B, Rodriguez AC, Jerónimo J, Cheung LC, Desai K, Han P, Novetsky AP, Ukwuani A, Marcus J, Ahmed SR, ... Wentzensen N, et al. Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy. Elife. 12. PMID 38224340 DOI: 10.7554/eLife.91469 |
0.372 |
|
| 2023 |
Simms KT, Keane A, Nguyen DTN, Caruana M, Hall MT, Lui G, Gauvreau C, Demke O, Arbyn M, Basu P, Wentzensen N, Lauby-Secretan B, Ilbawi A, Hutubessy R, Almonte M, et al. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nature Medicine. 29: 3050-3058. PMID 38087115 DOI: 10.1038/s41591-023-02600-4 |
0.372 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, et al. Reproducible and clinically translatable deep neural networks for cervical screening. Scientific Reports. 13: 21772. PMID 38066031 DOI: 10.1038/s41598-023-48721-1 |
0.357 |
|
| 2023 |
Perkins RB, Wentzensen N, Schiffman M. Primary HPV Screening vs Cotesting for Cervical Cancer-Reply. Jama. 330: 2121-2122. PMID 38051330 DOI: 10.1001/jama.2023.20373 |
0.427 |
|
| 2023 |
Inturrisi F, de Sanjosé S, Desai KT, Dagnall C, Egemen D, Befano B, Rodriguez AC, Jeronimo JA, Zuna RE, Hoffman A, Farhat Nozzari S, Walker JL, Perkins RB, Wentzensen N, Palefsky JM, et al. A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study. International Journal of Cancer. PMID 37772799 DOI: 10.1002/ijc.34698 |
0.402 |
|
| 2023 |
de Sanjosé S, Perkins RB, Campos NG, Inturrisi F, Egemen D, Befano B, Rodriguez AC, Jerónimo J, Cheung LC, Desai K, Han P, Novetsky AP, Ukwuani A, Marcus J, Ahmed SR, ... Wentzensen N, et al. Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy. Medrxiv : the Preprint Server For Health Sciences. PMID 37693492 DOI: 10.1101/2023.08.30.23294826 |
0.33 |
|
| 2023 |
Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical Cancer Screening: A Review. Jama. 330: 547-558. PMID 37552298 DOI: 10.1001/jama.2023.13174 |
0.426 |
|
| 2023 |
Gradissimo A, Clarke MA, Xue X, Castle PE, Raine-Bennett TR, Schiffman M, Wentzensen N, Strickler HD, Burk RD. A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma. Journal of the National Cancer Institute. PMID 37467068 DOI: 10.1093/jnci/djad134 |
0.374 |
|
| 2023 |
Clarke MA, Wentzensen N. Response to comments on: "A systematic review and meta-analysis of cytology and HPV-related biomarkers for anal cancer screening among different risk groups". International Journal of Cancer. 153: 1427-1428. PMID 37401760 DOI: 10.1002/ijc.34642 |
0.413 |
|
| 2023 |
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, et al. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 3081-3088. PMID 37285653 DOI: 10.1200/JCO.22.02625 |
0.353 |
|
| 2023 |
Schiffman M, Mirabello L, Egemen D, Befano B, Xiao Y, Wentzensen N, Raine-Bennett T, Nayar R, Cheung LC, Rositch A, Beaty T, Perkins RB, de Sanjose S, Lorey T, Castle PE, et al. The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma. Gynecologic Oncology. 174: 253-261. PMID 37243996 DOI: 10.1016/j.ygyno.2023.05.011 |
0.372 |
|
| 2023 |
Perkins RB, Smith DL, Jeronimo J, Campos NG, Gage JC, Hansen N, Rodriguez AC, Cheung LC, Egemen D, Befano B, Novetsky AP, Martins S, Kalpathy-Cramer J, Inturrisi F, Ahmed SR, ... ... Wentzensen N, et al. Use of risk-based cervical screening programs in resource-limited settings. Cancer Epidemiology. 84: 102369. PMID 37105017 DOI: 10.1016/j.canep.2023.102369 |
0.351 |
|
| 2023 |
Ahmed SR, Befano B, Lemay A, Egemen D, Rodriguez AC, Angara S, Desai K, Jeronimo J, Antani S, Campos N, Inturrisi F, Perkins R, Kreimer A, Wentzensen N, Herrero R, et al. Reproducible and Clinically Translatable Deep Neural Networks for Cancer Screening. Research Square. PMID 36909463 DOI: 10.21203/rs.3.rs-2526701/v1 |
0.381 |
|
| 2023 |
Hurwitz LM, Webb PM, Jordan SJ, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Schildkraut JM, Berchuck A, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, ... ... Wentzensen N, et al. Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. Jama Network Open. 6: e230666. PMID 36826816 DOI: 10.1001/jamanetworkopen.2023.0666 |
0.327 |
|
| 2023 |
Shi J, Kraft P, Rosner B, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, ... ... Wentzensen N, et al. Risk prediction models for endometrial cancer: development and validation in an international consortium. Journal of the National Cancer Institute. PMID 36688725 DOI: 10.1093/jnci/djad014 |
0.312 |
|
| 2023 |
Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Brooks-Wilson A, Chang-Claude J, Cook LS, Cramer DW, Cushing-Haugen KL, Doherty JA, ... ... Wentzensen N, et al. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. Journal of the National Cancer Institute. PMID 36688720 DOI: 10.1093/jnci/djad011 |
0.313 |
|
| 2022 |
Shahmoradi Z, Damgacioglu H, Clarke MA, Wentzensen N, Montealegre J, Sonawane K, Deshmukh AA. Cervical Cancer Incidence Among US Women, 2001-2019. Jama. 328: 2267-2269. PMID 36409512 DOI: 10.1001/jama.2022.17806 |
0.378 |
|
| 2022 |
Lou H, Boland JF, Li H, Burk R, Yeager M, Anderson SK, Wentzensen N, Schiffman M, Mirabello L, Dean M. HPV16 E7 Nucleotide Variants Found in Cancer-Free Subjects Affect E7 Protein Expression and Transformation. Cancers. 14. PMID 36230818 DOI: 10.3390/cancers14194895 |
0.344 |
|
| 2022 |
Arbyn M, Canfell K, Poljak M, Berkhof J, de Sanjosé S, Wentzensen N. HPV mRNA testing in cervical cancer screening - Authors' reply. The Lancet. Oncology. 23: e437. PMID 36174618 DOI: 10.1016/S1470-2045(22)00551-4 |
0.407 |
|
| 2022 |
Crous-Bou M, Du M, Gunter MJ, Setiawan VW, Schouten LJ, Shu XO, Wentzensen N, Bertrand KA, Cook LS, Friedenreich CM, Gapstur SM, Goodman MT, Ibiebele TI, La Vecchia C, Levi F, et al. Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2). The American Journal of Clinical Nutrition. PMID 36041172 DOI: 10.1093/ajcn/nqac229 |
0.32 |
|
| 2022 |
Hurwitz LM, Townsend MK, Jordan SJ, Patel AV, Teras LR, Lacey JV, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Robien K, Prizment A, Schildkraut JM, ... ... Wentzensen N, et al. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101900. PMID 35867953 DOI: 10.1200/JCO.21.01900 |
0.355 |
|
| 2022 |
Castle PE, Befano B, Schiffman M, Wentzensen N, Lorey T, Poitras N, Hyer M, Cheung LC. A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening. Preventive Medicine. 162: 107157. PMID 35810936 DOI: 10.1016/j.ypmed.2022.107157 |
0.373 |
|
| 2022 |
Clarke MA, Deshmukh AA, Suk R, Roberts J, Gilson R, Jay N, Stier EA, Wentzensen N. A Systematic Review and Meta-Analysis of Cytology and HPV-related Biomarkers for Anal Cancer Screening Among Different Risk Groups. International Journal of Cancer. PMID 35793241 DOI: 10.1002/ijc.34199 |
0.422 |
|
| 2022 |
Arbyn M, Simon M, de Sanjosé S, Clarke MA, Poljak M, Rezhake R, Berkhof J, Nyaga V, Gultekin M, Canfell K, Wentzensen N. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. The Lancet. Oncology. 23: 950-960. PMID 35709810 DOI: 10.1016/S1470-2045(22)00294-7 |
0.409 |
|
| 2022 |
Desai KT, Adepiti CA, Schiffman M, Egemen D, Gage JC, Wentzensen N, de Sanjose S, Burk RD, Ajenifuja KO. Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management. International Journal of Cancer. PMID 35666530 DOI: 10.1002/ijc.34151 |
0.396 |
|
| 2022 |
Adebamowo SN, Befano B, Cheung LC, Rodriguez AC, Demarco M, Rydzak G, Chen X, Porras C, Herrero R, Kim JJ, Castle PE, Wentzensen N, Kreimer AR, Schiffman M, Campos NG. Different Human Papillomavirus Types Share Early Natural History Transitions in Immunocompetent Women. International Journal of Cancer. PMID 35603904 DOI: 10.1002/ijc.34128 |
0.355 |
|
| 2022 |
Saraiya M, Colbert J, Bhat GL, Almonte R, Winters DW, Sebastian S, O'Hanlon M, Meadows G, Nosal MR, Richards TB, Michaels M, Townsend JS, Miller JW, Perkins RB, Sawaya GF, ... Wentzensen N, et al. Computable Guidelines and Clinical Decision Support for Cervical Cancer Screening and Management to Improve Outcomes and Health Equity. Journal of Women's Health (2002). 31: 462-468. PMID 35467443 DOI: 10.1089/jwh.2022.0100 |
0.344 |
|
| 2022 |
Sahasrabuddhe VV, Castle PE, Schiffman M, Wentzensen N, Heckman-Stoddard B, Arbyn M. Reply to: Comments on 'Meta-analysis of agreement/concordance statistics in studies comparing self- versus clinician-collected samples for HPV testing in cervical cancer screening'. International Journal of Cancer. PMID 35377490 DOI: 10.1002/ijc.34013 |
0.393 |
|
| 2022 |
Demarco M, Egemen D, Hyun N, Chen X, Moscicki AB, Cheung L, Carter-Pokras O, Hammer A, Gage JC, Clarke MA, Castle PE, Befano B, Chen J, Dallal C, He X, ... ... Wentzensen N, et al. Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test Results. Journal of Lower Genital Tract Disease. PMID 35249974 DOI: 10.1097/LGT.0000000000000667 |
0.405 |
|
| 2022 |
Arbyn M, Castle PE, Schiffman M, Wentzensen N, Heckman-Stoddard B, Sahasrabuddhe VV. Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening. International Journal of Cancer. PMID 35179777 DOI: 10.1002/ijc.33967 |
0.323 |
|
| 2022 |
Mix J, Saraiya M, Hallowell BD, Befano B, Cheung LC, Unger ER, Gargano JW, Markowitz LE, Castle PE, Raine-Bennett T, Walker J, Zuna R, Schiffman M, Wentzensen N, Gage JC. Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management. Journal of the National Cancer Institute. PMID 35176161 DOI: 10.1093/jnci/djac034 |
0.379 |
|
| 2022 |
Lauby-Secretan B, Mackie A, Wentzensen N. The IARC Perspective on Cervical Cancer Screening. Reply. The New England Journal of Medicine. 386: 607-608. PMID 35139285 DOI: 10.1056/NEJMc2119177 |
0.389 |
|
| 2022 |
Phung MT, Alimujiang A, Berchuck A, Anton-Cluver H, Schildkraut JM, Bandera EV, Chang-Claude J, Chase A, Doherty JA, Grout B, Goodman MT, Hanley GE, Lee AW, McKinnon Deurloo C, Menon U, ... ... Wentzensen N, et al. Reproductive factors do not influence survival with ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35064059 DOI: 10.1158/1055-9965.EPI-21-1091 |
0.303 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Wentzensen N, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.31 |
|
| 2021 |
Gage JC, Raine-Bennett T, Schiffman M, Clarke MA, Cheung LC, Poitras NE, Varnado NE, Katki HA, Castle PE, Befano B, Chandra M, Rydzak G, Lorey T, Wentzensen N. The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789470 DOI: 10.1158/1055-9965.EPI-21-0865 |
0.454 |
|
| 2021 |
Raine-Bennett T, Gage JC, Poitras N, Chandra M, Varnado N, Befano B, Schiffman M, Lorey T, Wentzensen N. Development of a large biorepository of cervical specimens for the Improving Risk Informed HPV Screening study (IRIS). Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 145: 105014. PMID 34768232 DOI: 10.1016/j.jcv.2021.105014 |
0.426 |
|
| 2021 |
Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, Kupets R, Smith R, Arrossi S, Bendahhou K, Canfell K, Chirenje ZM, Chung MH, Del Pino M, de Sanjosé S, et al. The IARC Perspective on Cervical Cancer Screening. The New England Journal of Medicine. 385: 1908-1918. PMID 34758259 DOI: 10.1056/NEJMsr2030640 |
0.388 |
|
| 2021 |
Clarke MA, Risley C, Stewart MW, Geisinger KR, Hiser LM, Morgan JC, Owens KJ, Ayyalasomayajula K, Rives RM, Jannela A, Grunes DE, Zhang L, Schiffman M, Wagner S, Boland J, ... ... Wentzensen N, et al. Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi. Cancer Medicine. PMID 34734483 DOI: 10.1002/cam4.4340 |
0.429 |
|
| 2021 |
Pinheiro M, Harari A, Schiffman M, Clifford GM, Chen Z, Yeager M, Cullen M, Boland JF, Raine-Bennett T, Steinberg M, Bass S, Xiao Y, Tenet V, Yu K, Zhu B, ... ... Wentzensen N, et al. Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes. Viruses. 13. PMID 34696378 DOI: 10.3390/v13101948 |
0.381 |
|
| 2021 |
Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, Giles GG, Irvin SR, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Koh WP, Lacey JV, Langseth H, ... ... Wentzensen N, et al. Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). International Journal of Epidemiology. PMID 34652432 DOI: 10.1093/ije/dyab211 |
0.304 |
|
| 2021 |
Locke A, Shah NR, Fetterman B, Poitras N, Wi S, Castle PE, Wentzensen N, Kinney W, Clarke MA, Lorey T. Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result. Obstetrics and Gynecology. 138: 580-581. PMID 34623071 DOI: 10.1097/AOG.0000000000004543 |
0.335 |
|
| 2021 |
Ribeiro A, Corrêa F, Migowski A, Leal A, Martins S, Raiol T, Marques CP, Torres KL, Novetsky AP, Marcus JZ, Wentzensen N, Schiffman M, Rodriguez AC, Gage JC. Rethinking Cervical Cancer Screening in Brazil Post COVID-19: A Global Opportunity to Adopt Higher Impact Strategies. Cancer Prevention Research (Philadelphia, Pa.). 14: 919-926. PMID 34607876 DOI: 10.1158/1940-6207.CAPR-21-0110 |
0.356 |
|
| 2021 |
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. 25: 330-331. PMID 34542089 DOI: 10.1097/LGT.0000000000000628 |
0.398 |
|
| 2021 |
Wentzensen N, O'Brien KM. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence. Gynecologic Oncology. 163: 199-208. PMID 34366148 DOI: 10.1016/j.ygyno.2021.07.032 |
0.354 |
|
| 2021 |
Risley C, Stewart MW, Geisinger KR, Hiser LM, Morgan JC, Owens KJ, Ayyalasomayajula K, Rives RM, Jannela A, Grunes DE, Zhang L, Schiffman M, Wentzensen N, Clarke MA. STRIDES - STudying Risk to Improve DisparitiES in Cervical Cancer in Mississippi - Design and baseline results of a Statewide Cohort Study. Preventive Medicine. 106740. PMID 34293382 DOI: 10.1016/j.ypmed.2021.106740 |
0.399 |
|
| 2021 |
Wentzensen N, Clarke MA, Perkins RB. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities. Preventive Medicine. 151: 106596. PMID 34217415 DOI: 10.1016/j.ypmed.2021.106596 |
0.408 |
|
| 2021 |
Bee KJ, Gradissimo A, Chen Z, Harari A, Schiffman M, Raine-Bennett T, Castle PE, Clarke M, Wentzensen N, Burk RD. Genetic and Epigenetic Variations of HPV52 in Cervical Precancer. International Journal of Molecular Sciences. 22. PMID 34208758 DOI: 10.3390/ijms22126463 |
0.403 |
|
| 2021 |
Virani S, Baiocchi G, Bowtell D, Cabasag CJ, Cho KR, Fortner RT, Fujiwara K, Kim JW, Köbel M, Kurtz JE, Levine DA, Menon U, Norquist BM, Pharoah PDP, Sood AK, ... ... Wentzensen N, et al. Joint IARC/NCI International Cancer Seminar Series Report: Expert consensus on future directions for ovarian carcinoma research. Carcinogenesis. PMID 34037709 DOI: 10.1093/carcin/bgab043 |
0.308 |
|
| 2021 |
Arbyn M, Simon M, Peeters E, Meijer CJLM, Berkhof J, Cuschieri K, Bonde J, Oštrbenk Valenčak A, Zhao FH, Rezhake R, Gultekin M, Dillner J, de Sanjosé S, Canfell K, Hillemanns P, ... ... Wentzensen N, et al. 2020 List of human papillomavirus assays Suitable for primary cervical cancer screening. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 33975008 DOI: 10.1016/j.cmi.2021.04.031 |
0.428 |
|
| 2021 |
Wentzensen N, Clarke MA. Cervical Cancer Screening-Past, Present, and Future. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 30: 432-434. PMID 33857013 DOI: 10.1158/1055-9965.EPI-20-1628 |
0.421 |
|
| 2021 |
Aron J, Albert PS, Wentzensen N, Cheung LC. Hidden mover-stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer. Statistics in Medicine. PMID 33845514 DOI: 10.1002/sim.8977 |
0.368 |
|
| 2021 |
Wentzensen N, Chirenje ZM, Prendiville W. Treatment approaches for women with positive cervical screening results in low-and middle-income countries. Preventive Medicine. 144: 106439. PMID 33678236 DOI: 10.1016/j.ypmed.2021.106439 |
0.346 |
|
| 2021 |
Perkins RB, Guido RL, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M, Feldman S. Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020. Journal of Women's Health (2002). 30: 5-13. PMID 33464997 DOI: 10.1089/jwh.2020.8918 |
0.342 |
|
| 2021 |
Castle PE, Locke A, Tergas AI, Befano B, Poitras N, Shah NR, Schiffman M, Wentzensen N, Strickler HD, Clarke MA, Lorey T. The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses. Gynecologic Oncology. PMID 33454132 DOI: 10.1016/j.ygyno.2021.01.005 |
0.452 |
|
| 2021 |
O'Brien KM, Tworoger SS, Harris HR, Trabert B, Weinberg CR, Fortner RT, D'Aloisio AA, Kaunitz AM, Wentzensen N, Sandler DP. Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies. International Journal of Cancer. PMID 33433939 DOI: 10.1002/ijc.33470 |
0.309 |
|
| 2021 |
Luhn P, Wentzensen N. HPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease. Current Obstetrics and Gynecology Reports. 2: 76-85. PMID 23705102 DOI: 10.1007/s13669-013-0040-0 |
0.427 |
|
| 2020 |
Litwin TR, Irvin SR, Chornock RL, Sahasrabuddhe VV, Stanley M, Wentzensen N. Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis. British Journal of Cancer. PMID 33257839 DOI: 10.1038/s41416-020-01184-x |
0.342 |
|
| 2020 |
Desai KT, Ajenifuja KO, Banjo A, Adepiti CA, Novetsky A, Sebag C, Einstein MH, Oyinloye T, Litwin TR, Horning M, Olanrewaju FO, Oripelaye MM, Afolabi E, Odujoko OO, Castle PE, ... ... Wentzensen N, et al. Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage. Infectious Agents and Cancer. 15: 60. PMID 33072178 DOI: 10.1186/s13027-020-00324-5 |
0.342 |
|
| 2020 |
Saraiya M, Cheung L, Soman A, Mix J, Kenney K, Chen X, Perkins RB, Schiffman M, Wentzensen N, Miller J. Risk of Cervical Precancer and Cancer Among Uninsured and Underserved Women 2009-2017. American Journal of Obstetrics and Gynecology. PMID 33035473 DOI: 10.1016/j.ajog.2020.10.001 |
0.315 |
|
| 2020 |
Lee AW, Rosenzweig S, Wiensch A, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. Journal of the National Cancer Institute. PMID 32766851 DOI: 10.1093/Jnci/Djaa099 |
0.324 |
|
| 2020 |
Schiffman M, Wentzensen N. The Orderly Incorporation of Continuing Technologic Advances Into Cervical Cancer Screening. Journal of the National Cancer Institute. PMID 32745173 DOI: 10.1093/Jnci/Djaa106 |
0.333 |
|
| 2020 |
Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. PMID 32732648 DOI: 10.1097/Lgt.0000000000000562 |
0.392 |
|
| 2020 |
Fortner RT, Rice MS, Knutsen SF, Orlich MJ, Visvanathan K, Patel AV, Gaudet MM, Tjonneland A, Kvaskoff M, Kaaks R, Trichopoulou A, Pala V, Onland-Moret NC, Gram IT, Amiano P, ... ... Wentzensen N, et al. Ovarian cancer risk factor associations by primary anatomic site: the Ovarian Cancer Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32732252 DOI: 10.1158/1055-9965.Epi-20-0354 |
0.323 |
|
| 2020 |
Lou H, Boland JF, Torres-Gonzalez E, Albanez A, Zhou W, Steinberg MK, Diaw L, Mitchell J, Roberson D, Cullen M, Garland L, Bass S, Burk RD, Yeager M, Wentzensen N, et al. The D2 and D3 sublineages of human papillomavirus 16-positive cervical cancer in Guatemala differ in integration rate and age of diagnosis. Cancer Research. PMID 32631904 DOI: 10.1158/0008-5472.Can-20-0029 |
0.336 |
|
| 2020 |
Wentzensen N, Lahrmann B, Clarke MA, Kinney W, Tokugawa D, Poitras N, Locke A, Bartels L, Krauthoff A, Walker J, Zuna R, Grewal KK, Goldhoff PE, Kingery JD, Castle PE, et al. Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening. Journal of the National Cancer Institute. PMID 32584382 DOI: 10.1093/Jnci/Djaa066 |
0.375 |
|
| 2020 |
Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, Befano B, Perkins RB, He X, Dallal C, Chen J, ... ... Wentzensen N, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. Eclinicalmedicine. 22: 100293. PMID 32510043 DOI: 10.1016/J.Eclinm.2020.100293 |
0.434 |
|
| 2020 |
Pinheiro M, Gage JC, Clifford GM, Demarco M, Cheung LC, Chen Z, Yeager M, Cullen M, Boland JF, Chen X, Raine-Bennett T, Steinberg M, Bass S, Befano B, Xiao Y, ... ... Wentzensen N, et al. Association of HPV35 with cervical carcinogenesis among women of African ancestry: evidence of viral-host interaction with implications for disease intervention. International Journal of Cancer. PMID 32363580 DOI: 10.1002/Ijc.33033 |
0.384 |
|
| 2020 |
Clarke MA, Long BJ, Sherman ME, Lemens MA, Podratz KC, Hopkins MR, Ahlberg LJ, Guire LJM, Laughlin-Tommaso SK, Bakkum-Gamez JN, Wentzensen N. Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms. American Journal of Obstetrics and Gynecology. PMID 32268124 DOI: 10.1016/j.ajog.2020.03.032 |
0.343 |
|
| 2020 |
Risley C, Clarke MA, Geisinger KR, Stewart MW, Zhang L, Hoover KW, Hiser LM, Owens K, DeMarco M, Schiffman M, Wentzensen N. Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix. Cancer Cytopathology. PMID 32243726 DOI: 10.1002/Cncy.22267 |
0.339 |
|
| 2020 |
Clarke MA, Massad LS, Khan MJ, Smith KM, Guido RS, Mayeaux EJ, Darragh TM, Huh WK, Johnson AL, Gold MA, Schiffman M, Wentzensen N. Challenges Associated With Cervical Cancer Screening and Management in Obese Women: A Provider Perspective. Journal of Lower Genital Tract Disease. 24: 184-191. PMID 32243314 DOI: 10.1097/Lgt.0000000000000506 |
0.385 |
|
| 2020 |
Demarco M, Egemen D, Raine-Bennett TR, Cheung LC, Befano B, Poitras NE, Lorey TS, Chen X, Gage JC, Castle PE, Wentzensen N, Perkins RB, Guido RS, Schiffman M. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease. 24: 144-147. PMID 32243309 DOI: 10.1097/Lgt.0000000000000530 |
0.39 |
|
| 2020 |
Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, Poitras N, Befano B, Locke A, Guido RS, Wiser AL, Gage JC, Katki HA, Wentzensen N, Castle PE, et al. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease. 24: 132-143. PMID 32243308 DOI: 10.1097/Lgt.0000000000000529 |
0.341 |
|
| 2020 |
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease. 24: 102-131. PMID 32243307 DOI: 10.1097/Lgt.0000000000000525 |
0.398 |
|
| 2020 |
Hammer A, Demarco M, Campos N, Befano B, Gravitt PE, Cheung L, Lorey TS, Poitras N, Kinney W, Wentzensen N, Castle PE, Schiffman M. Study of the Risks of CIN3+ detection following multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California. International Journal of Cancer. PMID 32141607 DOI: 10.1002/Ijc.32950 |
0.38 |
|
| 2020 |
Zhu B, Xiao Y, Yeager M, Clifford G, Wentzensen N, Cullen M, Boland JF, Bass S, Steinberg MK, Raine-Bennett T, Lee D, Burk RD, Pinheiro M, Song L, Dean M, et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nature Communications. 11: 886. PMID 32060290 DOI: 10.1038/S41467-020-14730-1 |
0.318 |
|
| 2020 |
Venetianer R, Clarke MA, van der Marel J, Tota J, Schiffman M, Dunn ST, Walker J, Zuna R, Quint W, Wentzensen N. Identification of HPV Genotypes Causing Cervical Pre-Cancer using Tissue-Based Genotyping. International Journal of Cancer. PMID 32037535 DOI: 10.1002/Ijc.32919 |
0.365 |
|
| 2020 |
Trabert B, Tworoger SS, O'Brien KM, Townsend MK, Fortner RT, Iversen ES, Hartge P, White E, Amiano P, Arslan AA, Bernstein L, Brinton LA, Buring JE, Dossus L, Fraser GE, ... ... Wentzensen N, et al. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Research. PMID 31932455 DOI: 10.1158/0008-5472.Can-19-2850 |
0.351 |
|
| 2020 |
O'Brien KM, Tworoger SS, Harris HR, Anderson GL, Weinberg CR, Trabert B, Kaunitz AM, D'Aloisio AA, Sandler DP, Wentzensen N. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. Jama. 323: 49-59. PMID 31910280 DOI: 10.1097/Ogx.0000000000000795 |
0.316 |
|
| 2019 |
Clarke MA, Long BJ, Sherman ME, Lemens MA, Podratz KC, Hopkins MR, Ahlberg LJ, Mc Guire LJ, Laughlin-Tommaso SK, Wentzensen N, Bakkum-Gamez JN. A prospective clinical cohort study of women at increased risk for endometrial cancer. Gynecologic Oncology. PMID 31718832 DOI: 10.1016/j.ygyno.2019.09.014 |
0.312 |
|
| 2019 |
Wagner S, Roberson D, Boland J, Kreimer AR, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Porras C, Cortes B, Sampson J, Herrero R, Rodriguez AC, ... ... Wentzensen N, et al. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes. The Journal of Infectious Diseases. PMID 31536132 DOI: 10.1093/Infdis/Jiz324 |
0.335 |
|
| 2019 |
Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, Arslan AA, Dossus L, Fortner RT, Gram IT, Hartge P, Idahl A, Kaaks R, Kvaskoff M, Magiocco A, ... ... Wentzensen N, et al. High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium. Cancer Research. PMID 31462430 DOI: 10.1158/0008-5472.Can-19-1554 |
0.335 |
|
| 2019 |
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, ... ... Wentzensen N, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/Ije/Dyz113 |
0.3 |
|
| 2019 |
Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. Jama Internal Medicine. PMID 31081870 DOI: 10.1001/Jamainternmed.2019.0306 |
0.413 |
|
| 2019 |
Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE. Absolute risks of cervical precancer among women who fulfil exiting guidelines based on HPV and cytology cotesting. International Journal of Cancer. PMID 30861114 DOI: 10.1002/Ijc.32268 |
0.401 |
|
| 2019 |
Wagner S, Roberson D, Boland J, Yeager M, Cullen M, Mirabello L, Dunn ST, Walker J, Zuna R, Schiffman M, Wentzensen N. Development of the TypeSeq Assay for Detection of 51 HPV Genotypes by Next Generation Sequencing. Journal of Clinical Microbiology. PMID 30814267 DOI: 10.1128/Jcm.01794-18 |
0.326 |
|
| 2019 |
Peeters E, Wentzensen N, Bergeron C, Arbyn M. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology. Cancer Cytopathology. 127: 169-180. PMID 30811902 DOI: 10.1002/cncy.22103 |
0.365 |
|
| 2019 |
Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, et al. Human Papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Research (Amsterdam, Netherlands). PMID 30738204 DOI: 10.1016/J.Pvr.2019.02.001 |
0.413 |
|
| 2019 |
Trabert B, Michels KA, Anderson GL, Brinton LA, Falk RT, Geczik AM, Harris HR, Pan K, Pfeiffer RM, Qi L, Rohan T, Wentzensen N, Xu X. Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. International Journal of Cancer. PMID 30684389 DOI: 10.1002/Ijc.32157 |
0.345 |
|
| 2019 |
Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, Gachuhi N, Wilson B, Jaiswal MS, Befano B, Long LR, Herrero R, Einstein MH, Burk RD, Demarco M, ... ... Wentzensen N, et al. An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening. Journal of the National Cancer Institute. PMID 30629194 DOI: 10.1097/Ogx.0000000000000687 |
0.344 |
|
| 2018 |
Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Poitras NE, Lorey TS, Katki HA, Wentzensen N, Schiffman M. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results. Journal of the National Cancer Institute. PMID 30576462 DOI: 10.1093/Jnci/Djy192 |
0.358 |
|
| 2018 |
Fortner RT, Poole EM, Wentzensen NA, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, et al. Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium. International Journal of Cancer. PMID 30561796 DOI: 10.1002/Ijc.32075 |
0.314 |
|
| 2018 |
Clarke MA, Cheung LC, Lorey T, Hare B, Landy R, Tokugawa D, Gage JC, Darragh TM, Castle PE, Wentzensen N. Five-year prospective evaluation of cytology, HPV testing, and biomarkers for detection of anal precancer in HIV+ MSM. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30418518 DOI: 10.1093/cid/ciy970 |
0.303 |
|
| 2018 |
Conrad RD, Liu AH, Wentzensen N, Zhang RR, Dunn ST, Wang SS, Schiffman M, Gold MA, Walker JL, Zuna RE. Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathology. PMID 30351473 DOI: 10.1002/Cncy.22055 |
0.368 |
|
| 2018 |
Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women. Jama Oncology. PMID 30325982 DOI: 10.1001/Jamaoncol.2018.4270 |
0.422 |
|
| 2018 |
Castle PE, Xie X, Xue X, Poitras NE, Lorey TS, Kinney WK, Wentzensen N, Strickler HD, Burger EA, Schiffman M. Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results. Preventive Medicine. PMID 30316878 DOI: 10.1016/J.Ypmed.2018.10.001 |
0.347 |
|
| 2018 |
Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, ... ... Wentzensen N, et al. HLA and KIR Associations of Cervical Neoplasia. The Journal of Infectious Diseases. PMID 30099516 DOI: 10.1093/Infdis/Jiy483 |
0.363 |
|
| 2018 |
Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, Smith KM, Wentzensen N. Risk of Cervical Intraepithelial Neoplasia 2 or Worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: A Systematic Review and Meta-analysis. Obstetrics and Gynecology. PMID 30095780 DOI: 10.1097/Aog.0000000000002812 |
0.357 |
|
| 2018 |
O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, ... ... Wentzensen N, et al. Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. 9: 3166. PMID 30093612 DOI: 10.1038/S41467-018-05427-7 |
0.325 |
|
| 2018 |
Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. Jama Internal Medicine. PMID 30083701 DOI: 10.1001/jamainternmed.2018.2820 |
0.347 |
|
| 2018 |
Trabert B, Poole EM, White E, Visvanathan K, Adami HO, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV, Larsson SC, ... ... Wentzensen N, et al. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. Journal of the National Cancer Institute. PMID 29860330 DOI: 10.1097/Ogx.0000000000000601 |
0.342 |
|
| 2018 |
Clarke MA, Wentzensen N. Strategies for screening and early detection of anal cancers: A narrative and systematic review and meta-analysis of cytology, HPV testing, and other biomarkers. Cancer Cytopathology. PMID 29797691 DOI: 10.1002/cncy.22018 |
0.471 |
|
| 2018 |
Trabert B, Waterboer T, Idahl A, Brenner N, Brinton LA, Butt J, Coburn SB, Hartge P, Hufnagel K, Inturrisi F, Lissowska J, Mentzer A, Peplonska B, Sherman ME, Wills GS, ... ... Wentzensen N, et al. Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations. Journal of the National Cancer Institute. PMID 29790947 DOI: 10.1093/jnci/djy084 |
0.332 |
|
| 2018 |
Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M. Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology. Journal of the National Cancer Institute. PMID 29659930 DOI: 10.1093/Jnci/Djy044 |
0.402 |
|
| 2018 |
Demarco M, Cheung LC, Kinney WK, Wentzensen N, Lorey TS, Fetterman B, Poitras NE, Befano B, Castle PE, Schiffman M. Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy. Journal of Lower Genital Tract Disease. 22: 97-103. PMID 29570564 DOI: 10.1097/Lgt.0000000000000382 |
0.371 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Wentzensen N, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.322 |
|
| 2018 |
Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M. Validation of an HPV DNA cervical screening test that provides expanded HPV typing. Journal of Clinical Microbiology. PMID 29491018 DOI: 10.1128/Jcm.01910-17 |
0.347 |
|
| 2018 |
Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. American Journal of Obstetrics and Gynecology. PMID 29462629 DOI: 10.1016/J.Ajog.2018.02.009 |
0.362 |
|
| 2018 |
Mirabello L, Clarke MA, Nelson CW, Dean M, Wentzensen N, Yeager M, Cullen M, Boland JF, Schiffman M, Burk RD. The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses. 10. PMID 29438321 DOI: 10.3390/V10020080 |
0.347 |
|
| 2018 |
Clarke MA, Gradíssimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras NE, Raine-Bennett T, Castle PE, Wentzensen N, Burk RD. Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29420222 DOI: 10.1158/1078-0432.Ccr-17-3251 |
0.375 |
|
| 2018 |
Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M. Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017753442. PMID 29356609 DOI: 10.1200/Jco.2017.75.3442 |
0.391 |
|
| 2018 |
Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L, Carozzi F, Cubie H, Wentzensen N, Snijders P, Arbyn M, Monsonego J J, Franceschi S. Eurogin Roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programmes. International Journal of Cancer. PMID 29341110 DOI: 10.1002/Ijc.31261 |
0.385 |
|
| 2018 |
Wentzensen N, Schiffman M. Accelerating cervical cancer control and prevention. The Lancet. Public Health. 3: e6-e7. PMID 29307389 DOI: 10.1016/S2468-2667(17)30242-6 |
0.38 |
|
| 2017 |
Castle PE, Kinney WK, Xue X, Cheung LC, Gage JC, Zhao FH, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Katki HA, Schiffman M. Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study. Annals of Internal Medicine. PMID 29181509 DOI: 10.7326/M17-1609 |
0.42 |
|
| 2017 |
Schiffman M, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Castle PE. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening. Journal of the National Cancer Institute. PMID 29145648 DOI: 10.1093/Jnci/Djx225 |
0.406 |
|
| 2017 |
Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, ... ... Wentzensen N, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.Epi-17-0655 |
0.332 |
|
| 2017 |
Doherty JA, Jensen A, Kelemen LE, Pearce CL, Poole E, Schildkraut JM, Terry KL, Tworoger SS, Webb PM, Wentzensen N. Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. Journal of the National Cancer Institute. 109. PMID 29117355 DOI: 10.1093/Jnci/Djx144 |
0.315 |
|
| 2017 |
Liu AH, Walker J, Gage JC, Gold MA, Zuna R, Dunn ST, Schiffman M, Wentzensen N. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology. Obstetrics and Gynecology. PMID 29112672 DOI: 10.1097/Aog.0000000000002330 |
0.352 |
|
| 2017 |
Schiffman M, Wentzensen N. Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions. Preventive Medicine. 105: 378-380. PMID 29056320 DOI: 10.1016/J.Ypmed.2017.09.010 |
0.369 |
|
| 2017 |
Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, Kinney WK, Poitras NE, Befano B, Castle PE, Schiffman M. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. Journal of Lower Genital Tract Disease. 21: 261-267. PMID 28953116 DOI: 10.1097/Lgt.0000000000000343 |
0.426 |
|
| 2017 |
Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, Mayeaux EJ, Waxman AG, Huh WK, Massad LS. ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice. Journal of Lower Genital Tract Disease. 21: 230-234. PMID 28953111 DOI: 10.1097/Lgt.0000000000000334 |
0.359 |
|
| 2017 |
Wentzensen N, Massad LS, Mayeaux EJ, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, Chelmow D, Choma KK, Darragh TM, Gage JC, Garcia FAR, et al. Evidence-Based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. Journal of Lower Genital Tract Disease. 21: 216-222. PMID 28953109 DOI: 10.1097/LGT.0000000000000322 |
0.33 |
|
| 2017 |
Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 170: 1164-1174.e6. PMID 28886384 DOI: 10.1016/J.Cell.2017.08.001 |
0.388 |
|
| 2017 |
Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, ... ... Wentzensen N, et al. Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. Plos Genetics. 13: e1006866. PMID 28806749 DOI: 10.1371/Journal.Pgen.1006866 |
0.415 |
|
| 2017 |
Litwin TR, Clarke MA, Dean M, Wentzensen N. Somatic Host Cell Alterations in HPV Carcinogenesis. Viruses. 9. PMID 28771191 DOI: 10.3390/v9080206 |
0.354 |
|
| 2017 |
Castle PE, Kinney WK, Cheung LC, Gage JC, Fetterman B, Poitras NE, Lorey TS, Wentzensen N, Befano B, Schussler J, Katki HA, Schiffman M. Why does cervical cancer occur in a state-of-the-art screening program? Gynecologic Oncology. PMID 28606721 DOI: 10.1016/J.Ygyno.2017.06.003 |
0.436 |
|
| 2017 |
Fokom Domgue J, Schiffman M, Wentzensen NH, Gage JC, Castle PE, Raine-Bennett TR, Fetterman B, Lorey T, Poitras NE, Befano B, Xie Y, Miachon LS, Dean M. Assessment of a new lower-cost real-time PCR detection assay for high-risk HPV: Useful for cervical screening in limited resource settings? Journal of Clinical Microbiology. PMID 28515214 DOI: 10.1128/Jcm.00492-17 |
0.378 |
|
| 2017 |
Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, Zuna R, Hewitt S, Killian JK, Yan L, Miller A, Schiffman M, Wentzensen N. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. International Journal of Cancer. PMID 28500655 DOI: 10.1002/Ijc.30781 |
0.415 |
|
| 2017 |
Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, ... ... Wentzensen N, et al. Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstetrics and Gynecology. PMID 28486362 DOI: 10.1097/Aog.0000000000002057 |
0.353 |
|
| 2017 |
Ose J, Poole EM, Schock H, Lehtinen M, Arslan AA, Zeleniuch-Jacquotte A, Visvanathan K, Helzlsouer KJ, Buring JE, Lee IM, Tjønneland A, Dossus L, Trichopoulou A, Masala G, Onland-Moret NC, ... ... Wentzensen N, et al. Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium. Cancer Research. PMID 28381542 DOI: 10.1158/0008-5472.Can-16-3322 |
0.303 |
|
| 2017 |
Wentzensen N, Arbyn M. HPV-based cervical cancer screening- facts, fiction, and misperceptions. Preventive Medicine. 98: 33-35. PMID 28279260 DOI: 10.1016/j.ypmed.2016.12.040 |
0.414 |
|
| 2017 |
Wentzensen N, Arbyn M, Berkhof J, Bower M, Canfell K, Einstein M, Farley C, Monsonego J, Franceschi S. Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice. International Journal of Cancer. 140: 2192-2200. PMID 28006858 DOI: 10.1002/ijc.30579 |
0.411 |
|
| 2016 |
Wentzensen N. [Epidemiology, prevention and early detection of cervical cancer]. Der Onkologe : Organ Der Deutschen Krebsgesellschaft E.V. 22: 725-736. PMID 28265177 DOI: 10.1007/s00761-016-0092-7 |
0.388 |
|
| 2016 |
Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus infection. Nature Reviews. Disease Primers. 2: 16086. PMID 27905473 DOI: 10.1038/nrdp.2016.86 |
0.4 |
|
| 2016 |
Beachler DC, Tota JE, Silver MI, Kreimer AR, Hildesheim A, Wentzensen N, Schiffman M, Shiels MS. Trends in cervical cancer incidence in younger US women from 2000 to 2013. Gynecologic Oncology. PMID 27894752 DOI: 10.1016/J.Ygyno.2016.11.031 |
0.354 |
|
| 2016 |
Arbyn M, Xu L, Verdoodt F, Cuzick J, Szarewski A, Belinson JL, Wentzensen N, Gage JC, Khan MJ. Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis. Annals of Internal Medicine. PMID 27842420 DOI: 10.7326/M15-2735 |
0.314 |
|
| 2016 |
Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LA, Myers O, Cuzick J, Wentzensen N, Kinney W, Castle PE, Wheeler CM. Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines. Obstetrics and Gynecology. PMID 27824767 DOI: 10.1097/Aog.0000000000001721 |
0.36 |
|
| 2016 |
Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, ... Wentzensen N, et al. Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. International Journal of Cancer. PMID 27770434 DOI: 10.1002/Ijc.30478 |
0.305 |
|
| 2016 |
Schiffman M, Yu K, Zuna R, Terence Dunn S, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki HA, Wentzensen N. Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have ≥CIN2. International Journal of Cancer. PMID 27696414 DOI: 10.1002/Ijc.30456 |
0.386 |
|
| 2016 |
Silver MI, Schiffman M, Fetterman B, Poitras NE, Gage JC, Wentzensen N, Lorey T, Kinney WK, Castle PE. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen. Cancer. PMID 27657992 DOI: 10.1002/Cncr.30277 |
0.435 |
|
| 2016 |
Schiffman M, Hyun N, Raine-Bennett TR, Katki H, Fetterman B, Gage JC, Cheung LC, Befano B, Poitras N, Lorey T, Castle PE, Wentzensen NH. A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage. International Journal of Cancer. PMID 27509172 DOI: 10.1002/Ijc.30375 |
0.381 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Wentzensen N, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.319 |
|
| 2016 |
Bodelon C, Untereiner ME, Machiela MJ, Vinokurova S, Wentzensen N. Genomic characterization of viral integration sites in HPV-related cancers. International Journal of Cancer. PMID 27343048 DOI: 10.1002/ijc.30243 |
0.345 |
|
| 2016 |
Arbyn M, Xu L, Wentzensen N. Reply to HPV test results provide useful risk stratification information in women with ASC-H Pap test findings. Cancer Cytopathology. PMID 27336222 DOI: 10.1002/cncy.21754 |
0.305 |
|
| 2016 |
Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27325851 DOI: 10.1200/Jco.2016.66.8178 |
0.334 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Wentzensen N, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.315 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Wentzensen N, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.306 |
|
| 2016 |
Yang HP, Murphy KR, Pfeiffer RM, George N, Garcia-Closas M, Lissowska J, Brinton LA, Wentzensen N. Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women. American Journal of Epidemiology. 183: 800-14. PMID 27190045 DOI: 10.1093/aje/kwv308 |
0.323 |
|
| 2016 |
Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, Zhang X, Yu K, Yang Q, Mitchell J, Roberson D, Bass S, Xiao Y, Burdett L, Raine-Bennett T, et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. Journal of the National Cancer Institute. 108. PMID 27130930 DOI: 10.1093/Jnci/Djw100 |
0.397 |
|
| 2016 |
Trabert B, Brinton LA, Anderson GL, Pfeiffer RM, Falk RT, Strickler HD, Sliesoraitis S, Kuller LH, Gass ML, Fuhrman BJ, Xu X, Wentzensen N. Circulating estrogens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26908437 DOI: 10.1158/1055-9965.Epi-15-1272-T |
0.312 |
|
| 2016 |
Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M. Risk assessment to guide cervical screening strategies in a large chinese population. International Journal of Cancer. Journal International Du Cancer. PMID 26800481 DOI: 10.1002/Ijc.30012 |
0.4 |
|
| 2016 |
Schiffman M, Wentzensen N. A Suggested Approach to Simplify and Improve Cervical Screening in the United States. Journal of Lower Genital Tract Disease. 20: 1-7. PMID 26704326 DOI: 10.1097/Lgt.0000000000000170 |
0.405 |
|
| 2016 |
Van Baars R, Van Der Marel J, Snijders PJF, Rodriquez-Manfredi A, Ter Harmsel B, Van Den Munckhof HAM, Ordi J, Del Pino M, Van De Sandt MM, Wentzensen N, Meijer CJLM, Quint WGV. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies International Journal of Cancer. 138: 463-471. PMID 26219541 DOI: 10.1002/ijc.29706 |
0.33 |
|
| 2016 |
Schiffman M, Wentzensen N. A Suggested Approach to Simplify and Improve Cervical Screening in the United States Journal of Lower Genital Tract Disease. 20: 1-7. DOI: 10.1097/LGT.0000000000000170 |
0.407 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Wentzensen N, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.31 |
|
| 2015 |
Beachler DC, Jenkins G, Safaeian M, Kreimer AR, Wentzensen N. Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis. The Journal of Infectious Diseases. PMID 26690341 DOI: 10.1093/Infdis/Jiv753 |
0.323 |
|
| 2015 |
Bodelon C, Vinokourova S, Sampson JN, den Boon JA, Walker JL, Horswill MA, Korthauer K, Schiffman M, Sherman ME, Zuna RE, Mitchell J, Zhang X, Boland JF, Chaturvedi AK, Dunn T, ... ... Wentzensen N, et al. Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. Carcinogenesis. PMID 26660085 DOI: 10.1093/Carcin/Bgv171 |
0.38 |
|
| 2015 |
Cullen M, Boland JF, Schiffman M, Zhang X, Wentzensen N, Yang Q, Chen Z, Yu K, Mitchell J, Roberson D, Bass S, Burdette L, Machado M, Ravichandran S, Luke B, et al. Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Research. 1: 3-11. PMID 26645052 DOI: 10.1016/J.Pvr.2015.05.004 |
0.373 |
|
| 2015 |
Wentzensen N, Schiffman M, Palmer T, Arbyn M. Triage of HPV positive women in cervical cancer screening. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. PMID 26643050 DOI: 10.1016/J.Jcv.2015.11.015 |
0.427 |
|
| 2015 |
Xu L, Verdoodt F, Wentzensen N, Bergeron C, Arbyn M. Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer. Cancer Cytopathology. PMID 26618614 DOI: 10.1002/cncy.21661 |
0.342 |
|
| 2015 |
Castro FA, Koshiol J, Quint W, Wheeler CM, Gillison ML, Vaughan LM, Kleter B, van Doorn LJ, Chaturvedi AK, Hildesheim A, Schiffman M, Wang SS, Zuna RE, Walker JL, Dunn ST, ... Wentzensen N, et al. Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods. Bmc Infectious Diseases. 15: 544. PMID 26607224 DOI: 10.1186/S12879-015-1281-5 |
0.343 |
|
| 2015 |
Mai S, Welzel G, Ottstadt M, Lohr F, Severa S, Prigge ES, Wentzensen N, Trunk MJ, Wenz F, von Knebel-Doeberitz M, Reuschenbach M. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer. International Journal of Radiation Oncology, Biology, Physics. 93: 819-27. PMID 26530750 DOI: 10.1016/j.ijrobp.2015.08.004 |
0.381 |
|
| 2015 |
Yang HP, Meeker A, Guido R, Gunter MJ, Huang GS, Luhn P, d'Ambrosio L, Wentzensen N, Sherman ME. PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors. Cancer Causes & Control : Ccc. PMID 26376893 DOI: 10.1007/S10552-015-0666-5 |
0.336 |
|
| 2015 |
Wentzensen N, Fetterman B, Castle PE, Schiffman M, Wood SN, Stiemerling E, Tokugawa D, Bodelon C, Poitras N, Lorey T, Kinney W. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. Journal of the National Cancer Institute. 107. PMID 26376685 DOI: 10.1093/jnci/djv257 |
0.398 |
|
| 2015 |
Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N. A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results. Gynecologic Oncology. 138: 573-8. PMID 26148763 DOI: 10.1016/J.Ygyno.2015.06.040 |
0.367 |
|
| 2015 |
Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1304-10. PMID 26088703 DOI: 10.1158/1055-9965.Epi-14-1353 |
0.381 |
|
| 2015 |
den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, Schott M, Chung L, He Q, Lambert P, Walker J, ... ... Wentzensen N, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proceedings of the National Academy of Sciences of the United States of America. 112: E3255-64. PMID 26056290 DOI: 10.1073/Pnas.1509322112 |
0.393 |
|
| 2015 |
Frimer M, Sun C, McAndrew T, Smith B, Harari A, Chen Z, Mirabello L, Wentzensen N, Goldberg GL, Rodriguez AC, Schiffman M, Burk RD. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study. Gynecologic Oncology. 138: 94-100. PMID 26001326 DOI: 10.1016/J.Ygyno.2015.05.001 |
0.361 |
|
| 2015 |
Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era. Ecancermedicalscience. 9: 530. PMID 25987899 DOI: 10.3332/Ecancer.2015.530 |
0.336 |
|
| 2015 |
Schiffman M, Wentzensen N. Transitioning to a new era in cervical cancer screening Gynecologic Oncology. 136: 175-177. PMID 25680631 DOI: 10.1016/J.Ygyno.2015.01.538 |
0.34 |
|
| 2015 |
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Gynecologic Oncology. 136: 178-182. PMID 25579107 DOI: 10.1016/J.Ygyno.2014.12.022 |
0.324 |
|
| 2015 |
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Journal of Lower Genital Tract Disease. 19: 91-6. PMID 25574659 DOI: 10.1097/Lgt.0000000000000103 |
0.354 |
|
| 2015 |
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Obstetrics and Gynecology. 125: 330-7. PMID 25569009 DOI: 10.1097/Aog.0000000000000669 |
0.338 |
|
| 2015 |
Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B, Lee E, Horn-Ross PL, Kolonel LN, Kaunitz A, Liang X, ... ... Wentzensen N, et al. Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes & Control : Ccc. 26: 287-96. PMID 25534916 DOI: 10.1007/S10552-014-0510-3 |
0.327 |
|
| 2015 |
Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, Tenney M, Nugent E, Graubard BI, Wacholder S, Schiffman M. Multiple biopsies and detection of cervical cancer precursors at colposcopy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 83-9. PMID 25422481 DOI: 10.1200/Jco.2014.55.9948 |
0.393 |
|
| 2015 |
van der Marel J, Berkhof J, Ordi J, Torné A, Del Pino M, van Baars R, Schiffman M, Wentzensen N, Jenkins D, Quint WG. Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion? The American Journal of Surgical Pathology. 39: 496-504. PMID 25353286 DOI: 10.1097/Pas.0000000000000342 |
0.348 |
|
| 2015 |
Mirabello L, Frimer M, Harari A, McAndrew T, Smith B, Chen Z, Wentzensen N, Wacholder S, Castle PE, Raine-Bennett T, Schiffman M, Burk RD. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. International Journal of Cancer. Journal International Du Cancer. 136: E146-53. PMID 25081507 DOI: 10.1002/Ijc.29119 |
0.324 |
|
| 2015 |
Bergeron C, Ronco G, Reuschenbach M, Wentzensen N, Arbyn M, Stoler M, von Knebel Doeberitz M. The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments. International Journal of Cancer. Journal International Du Cancer. 136: 2741-51. PMID 24740700 DOI: 10.1002/ijc.28900 |
0.368 |
|
| 2015 |
Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era Ecancermedicalscience. 9. DOI: 10.3332/ecancer.2015.530 |
0.335 |
|
| 2015 |
Tworoger SS, Poole EM, Arslan AA, Butler LM, Kirsh V, Lacey JV, Lee I, Patel AV, Robien K, Rohan T, Sandler DP, Schouten LJ, Setiawan VW, Visvanathan K, Weiderpass E, ... ... Wentzensen N, et al. Abstract AS10: Ovarian cancer risk factor associations by tumor aggressiveness in the ovarian cancer cohort consortium (OC3) Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-As10 |
0.404 |
|
| 2015 |
Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE. The role of human papillomavirus genotyping in cervical cancer screening: A large-scale evaluation of the cobas HPV test Cancer Epidemiology Biomarkers and Prevention. 24: 1304-1310. DOI: 10.1158/1055-9965.EPI-14-1353 |
0.403 |
|
| 2015 |
Wentzensen N, Schiffman M, Chelmow D, Darragh TM, Waxman AG. Risk assessment approach to management The Bethesda System For Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 305-313. DOI: 10.1007/978-3-319-11074-5_12 |
0.349 |
|
| 2014 |
Reuschenbach M, Wentzensen N, Dijkstra MG, von Knebel Doeberitz M, Arbyn M. p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement American Journal of Clinical Pathology. 142: 767-772. PMID 25389329 DOI: 10.1309/AJCP3TPHV4TRIZEK |
0.372 |
|
| 2014 |
van der Marel J, van Baars R, Rodriguez A, Quint WG, van de Sandt MM, Berkhof J, Schiffman M, Torné A, Ordi J, Jenkins D, Verheijen RH, Helmerhorst TJ, Ter Harmsel B, Wentzensen N, Del Pino M. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy. Gynecologic Oncology. 135: 201-7. PMID 25204846 DOI: 10.1016/J.Ygyno.2014.08.040 |
0.306 |
|
| 2014 |
Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecologic Oncology. 135: 297-304. PMID 25158036 DOI: 10.1016/J.Ygyno.2014.08.025 |
0.313 |
|
| 2014 |
Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. Journal of the National Cancer Institute. 106. PMID 25038467 DOI: 10.1093/Jnci/Dju153 |
0.436 |
|
| 2014 |
Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Sahasrabuddhe VV, Chen J, Lorey TS, Gage JC, Fetterman B, Boyle S, Sadorra M, Tang SD, Darragh TM, Castle PE. Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men. Journal of Clinical Microbiology. 52: 2892-7. PMID 24899025 DOI: 10.1128/JCM.03517-13 |
0.36 |
|
| 2014 |
Zhao L, Wentzensen N, Zhang RR, Dunn ST, Gold MA, Wang SS, Schiffman M, Walker JL, Zuna RE. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathology. 122: 694-701. PMID 24888458 DOI: 10.1002/cncy.21443 |
0.398 |
|
| 2014 |
Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 414-7. PMID 24881489 DOI: 10.1016/J.Jcv.2014.04.016 |
0.387 |
|
| 2014 |
Setiawan VW, Schumacher F, Prescott J, Haessler J, Malinowski J, Wentzensen N, Yang H, Chanock S, Brinton L, Hartge P, Lissowska J, Park SL, Cheng I, Bush WS, Crawford DC, et al. Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia. Carcinogenesis. 35: 2068-73. PMID 24832084 DOI: 10.1093/Carcin/Bgu107 |
0.336 |
|
| 2014 |
Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, et al. Exome-wide association study of endometrial cancer in a multiethnic population. Plos One. 9: e97045. PMID 24810602 DOI: 10.1371/Journal.Pone.0097045 |
0.303 |
|
| 2014 |
Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. The Journal of Infectious Diseases. 210: 448-55. PMID 24569064 DOI: 10.1093/Infdis/Jiu104 |
0.314 |
|
| 2014 |
Wentzensen N, Schiffman M. Filling a gap in cervical cancer screening programmes The Lancet Oncology. 15: 249-251. PMID 24529698 DOI: 10.1016/S1470-2045(14)70073-7 |
0.415 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Wentzensen N, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.316 |
|
| 2014 |
Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. Journal of Clinical Microbiology. 52: 187-92. PMID 24197879 DOI: 10.1128/Jcm.01623-13 |
0.377 |
|
| 2014 |
Wentzensen N, Nason M, Schiffman M, Dodd L, Hunt WC, Wheeler CM. No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study. The Journal of Infectious Diseases. 209: 855-64. PMID 24179110 DOI: 10.1093/Infdis/Jit577 |
0.359 |
|
| 2014 |
Koshiol J, Sklavos M, Wentzensen N, Kemp T, Schiffman M, Dunn ST, Wang SS, Walker JL, Safaeian M, Zuna RE, Hildesheim A, Pfeiffer RM, Pinto LA. Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study. International Journal of Cancer. Journal International Du Cancer. 134: 411-25. PMID 23824624 DOI: 10.1002/Ijc.28354 |
0.374 |
|
| 2013 |
Bodelon C, Wentzensen N, Schonfeld SJ, Visvanathan K, Hartge P, Park Y, Pfeiffer RM. Hormonal risk factors and invasive epithelial ovarian cancer risk by parity. British Journal of Cancer. 109: 769-76. PMID 23820255 DOI: 10.1038/Bjc.2013.344 |
0.347 |
|
| 2013 |
Luhn P, Houldsworth J, Cahill L, Schiffman M, Castle PE, Zuna RE, Dunn ST, Gold MA, Walker J, Wentzensen N. Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecologic Oncology. 130: 595-600. PMID 23769811 DOI: 10.1016/J.Ygyno.2013.06.005 |
0.309 |
|
| 2013 |
Luhn P, Dallal CM, Weiss JM, Black A, Huang WY, Lacey JV, Hayes RB, Stanczyk FZ, Wentzensen N, Brinton LA. Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1304-12. PMID 23696194 DOI: 10.1097/01.Ogx.0000435526.35453.45 |
0.331 |
|
| 2013 |
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstetrics and Gynecology. 121: 829-46. PMID 23635684 DOI: 10.1097/AOG.0b013e3182883a34 |
0.388 |
|
| 2013 |
Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N. Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1095-101. PMID 23603204 DOI: 10.1158/1055-9965.Epi-12-1455 |
0.366 |
|
| 2013 |
Wilson LE, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N. Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study. International Journal of Cancer. Journal International Du Cancer. 133: 2172-81. PMID 23588935 DOI: 10.1002/Ijc.28215 |
0.364 |
|
| 2013 |
Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer Cancer Epidemiology Biomarkers and Prevention. 22: 553-560. PMID 23549399 DOI: 10.1158/1055-9965.Epi-12-1406 |
0.405 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Wentzensen N, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.328 |
|
| 2013 |
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Journal of Lower Genital Tract Disease. 17: S1-S27. PMID 23519301 DOI: 10.1097/Lgt.0B013E318287D329 |
0.388 |
|
| 2013 |
Gage JC, Schiffman M, Hunt WC, Joste N, Ghosh A, Wentzensen N, Wheeler CM. Cervical histopathology variability among laboratories: a population-based statewide investigation. American Journal of Clinical Pathology. 139: 330-5. PMID 23429369 DOI: 10.1309/Ajcpsd3Zxjxp7Nnb |
0.313 |
|
| 2013 |
Ajenifuja KO, Gage JC, Adepiti AC, Wentzensen N, Eklund C, Reilly M, Hutchinson M, Burk RD, Schiffman M. A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 507-12. PMID 23354369 DOI: 10.1097/Igc.0B013E318280F395 |
0.307 |
|
| 2013 |
Poole EM, Merritt MA, Jordan SJ, Yang HP, Hankinson SE, Park Y, Rosner B, Webb PM, Cramer DW, Wentzensen N, Terry KL, Tworoger SS. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 429-37. PMID 23307531 DOI: 10.1158/1055-9965.EPI-12-1183-T |
0.315 |
|
| 2013 |
Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, et al. HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. Plos One. 8: e53067. PMID 23301022 DOI: 10.1371/Journal.Pone.0053067 |
0.308 |
|
| 2013 |
Wentzensen N. Triage of HPV-positive women in cervical cancer screening The Lancet Oncology. 14: 107-109. PMID 23261357 DOI: 10.1016/S1470-2045(12)70568-5 |
0.424 |
|
| 2013 |
Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA, Smith K, Mathews C, Allen RA, Zhang R, Wang S, Wentzensen N. The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecologic Oncology. 128: 265-70. PMID 23146688 DOI: 10.1016/J.Ygyno.2012.11.003 |
0.408 |
|
| 2013 |
Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. International Journal of Cancer. Journal International Du Cancer. 132: 1412-22. PMID 22847263 DOI: 10.1002/Ijc.27750 |
0.319 |
|
| 2013 |
Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, LaMere BJ, Schwartz L, Gage JC, Fetterman B, Lorey T, Wentzensen N. Interrater agreement of anal cytology. Cancer Cytopathology. 121: 72-8. PMID 22811048 DOI: 10.1002/cncy.21218 |
0.449 |
|
| 2013 |
Trabert B, Wentzensen N, Yang HP, Sherman ME, Hollenbeck AR, Park Y, Brinton LA. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? International Journal of Cancer. Journal International Du Cancer. 132: 417-26. PMID 22553145 DOI: 10.1002/ijc.27623 |
0.301 |
|
| 2013 |
Halec G, Schmitt M, Dondog B, Sharkhuu E, Wentzensen N, Gheit T, Tommasino M, Kommoss F, Bosch FX, Franceschi S, Clifford G, Gissmann L, Pawlita M. Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer International Journal of Cancer. 132: 63-71. PMID 22514107 DOI: 10.1002/ijc.27605 |
0.372 |
|
| 2013 |
Wentzensen N, Walker J, Schiffman M, Yang HP, Zuna RE, Dunn ST, Allen RA, Zhang R, Sherman M, Gold MA, Wang SS. Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. International Journal of Cancer. Journal International Du Cancer. 132: 148-54. PMID 22488167 DOI: 10.1002/Ijc.27577 |
0.392 |
|
| 2013 |
Wentzensen N, Trabert B, Schildkraut J. Ovarian Cancer Women and Health. 1135-1145. DOI: 10.1016/B978-0-12-384978-6.00075-3 |
0.301 |
|
| 2012 |
Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. Journal of the National Cancer Institute. 104: 1738-49. PMID 23093560 DOI: 10.1093/Jnci/Djs425 |
0.353 |
|
| 2012 |
Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M, Burk RD. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 2125-37. PMID 23035178 DOI: 10.1158/1055-9965.Epi-12-0905 |
0.376 |
|
| 2012 |
Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, Sahasrabuddhe VV, Lamere B, Gage JC, Fetterman B, Darragh TM, Castle PE. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM. Aids (London, England). 26: 2185-92. PMID 23018436 DOI: 10.1097/QAD.0b013e328359f255 |
0.338 |
|
| 2012 |
Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, ... ... Wentzensen N, et al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. 23: 1805-10. PMID 22961099 DOI: 10.1007/S10552-012-0059-Y |
0.315 |
|
| 2012 |
Castle PE, Gravitt PE, Wentzensen N, Schiffman M. A descriptive analysis of prevalent vs incident cervical intraepithelial neoplasia grade 3 following minor cytologic abnormalities. American Journal of Clinical Pathology. 138: 241-6. PMID 22904136 DOI: 10.1309/Ajcpntk6G2Pxwhoo |
0.363 |
|
| 2012 |
Mathews CA, Stoner JA, Wentzensen N, Moxley KM, Tenney ME, Tuller ER, Myers T, Landrum LM, Lanneau G, Zuna RE, Gold MA, Wang SS, Walker JL. Tubal ligation frequency in Oklahoma women with cervical cancer. Gynecologic Oncology. 127: 278-82. PMID 22858904 DOI: 10.1016/J.Ygyno.2012.07.119 |
0.406 |
|
| 2012 |
Castle PE, Glass AG, Rush BB, Scott DR, Wentzensen N, Gage JC, Buckland J, Rydzak G, Lorincz AT, Wacholder S. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3044-50. PMID 22851570 DOI: 10.1200/JCO.2011.38.8389 |
0.426 |
|
| 2012 |
Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, ... ... Wentzensen N, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. American Journal of Epidemiology. 176: 269-78. PMID 22831825 DOI: 10.1093/Aje/Kws129 |
0.305 |
|
| 2012 |
Safaeian M, Ghosh A, Porras C, Lin SW, Rodriguez AC, Schiffman M, Wacholder S, Kemp T, Gonzalez P, Wentzensen N, Esser M, Meuree A, Matys K, Quint W, van Doorn LJ, et al. Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1547-54. PMID 22752082 DOI: 10.1158/1055-9965.Epi-12-0558 |
0.306 |
|
| 2012 |
Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4154-62. PMID 22675168 DOI: 10.1158/1078-0432.CCR-12-0270 |
0.416 |
|
| 2012 |
Arbyn M, De Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease International Journal of Cancer. 131: 1969-1982. PMID 22623137 DOI: 10.1002/Ijc.27650 |
0.415 |
|
| 2012 |
Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Hildesheim A, Herrero R, Wacholder S, Lorincz A, Burk RD. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. Journal of the National Cancer Institute. 104: 556-65. PMID 22448030 DOI: 10.1093/Jnci/Djs135 |
0.382 |
|
| 2012 |
Wentzensen N. Screening for anal cancer: Endpoints needed The Lancet Oncology. 13: 438-440. PMID 22445258 DOI: 10.1016/S1470-2045(12)70101-8 |
0.316 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American Journal of Clinical Pathology. 137: 516-42. PMID 22431528 DOI: 10.1309/Ajcptgd94Evrsjcg |
0.379 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Ca: a Cancer Journal For Clinicians. 62: 147-72. PMID 22422631 DOI: 10.3322/Caac.21139 |
0.379 |
|
| 2012 |
Van Der Marel J, Quint WGV, Schiffman M, Van De Sandt MM, Zuna RE, Terence Dunn S, Smith K, Mathews CA, Gold MA, Walker J, Wentzensen N. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16 International Journal of Cancer. 131. PMID 22419273 DOI: 10.1002/Ijc.27532 |
0.371 |
|
| 2012 |
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Journal of Lower Genital Tract Disease. 16: 175-204. PMID 22418039 DOI: 10.1097/Lgt.0B013E31824Ca9D5 |
0.369 |
|
| 2012 |
Wentzensen N, Gravitt PE, Long R, Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE, Sherman ME, Gold MA, Walker JL, Wang SS. Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. Journal of Clinical Microbiology. 50: 1564-70. PMID 22337992 DOI: 10.1128/Jcm.06240-11 |
0.354 |
|
| 2012 |
White KL, Schildkraut JM, Palmieri RT, Iversen ES, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, ... ... Wentzensen N, et al. Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Research. 72: 1064-9. PMID 22282663 DOI: 10.1158/0008-5472.Can-11-3512 |
0.305 |
|
| 2012 |
Yang HP, Zuna RE, Schiffman M, Walker JL, Sherman ME, Landrum LM, Moxley K, Gold MA, Dunn ST, Allen RA, Zhang R, Long R, Wang SS, Wentzensen N. Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3. Plos One. 7: e29051. PMID 22253702 DOI: 10.1371/Journal.Pone.0029051 |
0.432 |
|
| 2012 |
Katki HA, Wentzensen N. How might HPV testing be integrated into cervical screening? The Lancet Oncology. 13: 8-10. PMID 22177578 DOI: 10.1016/S1470-2045(11)70334-5 |
0.341 |
|
| 2012 |
Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Eklund C, Reilly M, Hutchinson M, Wacholder S, Harford J, Soliman AS, Burk RD, Schiffman M. The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. International Journal of Cancer. Journal International Du Cancer. 130: 2111-7. PMID 21630264 DOI: 10.1002/Ijc.26211 |
0.365 |
|
| 2012 |
Porras C, Wentzensen N, RodrÃguez AC, Morales J, Burk RD, Alfaro M, Hutchinson M, Herrero R, Hildesheim A, Sherman ME, Wacholder S, Solomon D, Schiffman M. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy. International Journal of Cancer. Journal International Du Cancer. 130: 1879-87. PMID 21607948 DOI: 10.1002/Ijc.26194 |
0.39 |
|
| 2011 |
Zuna RE, Tuller E, Wentzensen N, Mathews C, Allen RA, Shanesmith R, Dunn ST, Gold MA, Wang SS, Walker J, Schiffman M. HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer. Infectious Agents and Cancer. 6: 19. PMID 22035468 DOI: 10.1186/1750-9378-6-19 |
0.449 |
|
| 2011 |
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4294-301. PMID 21969503 DOI: 10.1200/Jco.2011.36.4596 |
0.353 |
|
| 2011 |
Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiology. 6: 1083-98. PMID 21958146 DOI: 10.2217/fmb.11.87 |
0.358 |
|
| 2011 |
Wentzensen N. Molecular diagnosis of HPV infections Pathologe. 32: 461-466. PMID 21845360 DOI: 10.1007/s00292-011-1475-6 |
0.418 |
|
| 2011 |
Clarke MA, Gage JC, Ajenifuja KO, Wentzensen NA, Adepiti AC, Wacholder S, Burk RD, Schiffman M. A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural Nigeria. Infectious Agents and Cancer. 6: 12. PMID 21801395 DOI: 10.1186/1750-9378-6-12 |
0.354 |
|
| 2011 |
Wentzensen N, Black A, Jacobs K, Yang HP, Berg CD, Caporaso N, Peters U, Ragard L, Buys SS, Chanock S, Hartge P. Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Plos One. 6: e21731. PMID 21750727 DOI: 10.1371/Journal.Pone.0021731 |
0.32 |
|
| 2011 |
Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, Buckland J, Sherman ME, Rydzak G, Kirk P, Lorincz AT, Wacholder S, Burk RD. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1398-409. PMID 21602310 DOI: 10.1158/1055-9965.Epi-11-0206 |
0.39 |
|
| 2011 |
Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T, Walker LC, Montgomery SB, Dermitzakis ET, Fahey P, Montgomery GW, Webb PM, Fasching PA, Beckmann MW, ... ... Wentzensen N, et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nature Genetics. 43: 451-4. PMID 21499250 DOI: 10.1038/Ng.812 |
0.331 |
|
| 2011 |
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. Journal of the National Cancer Institute. 103: 368-83. PMID 21282563 DOI: 10.1093/Jnci/Djq562 |
0.432 |
|
| 2011 |
Burks HR, Smith KM, Wentzensen N, Tenney M, Tuller E, Moxley K, Mathews C, Dunn ST, Wang SS, Gold MA. Risk of cervical intraepithelial neoplasia 2+ among women with a history of previous treatment for cervical intraepithelial neoplasia: ASCUS and LSIL Pap smears after treatment. Journal of Lower Genital Tract Disease. 15: 11-4. PMID 21192170 DOI: 10.1097/LGT.0b013e3181ed3d6d |
0.346 |
|
| 2010 |
Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE. Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Research. 70: 8578-86. PMID 20959485 DOI: 10.1158/0008-5472.Can-10-1188 |
0.326 |
|
| 2010 |
Reuschenbach M, Clad A, Von Knebel Doeberitz C, Wentzensen N, Rahmsdorf J, Schaffrath F, Griesser H, Freudenberg N, Von Knebel Doeberitz M. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results Gynecologic Oncology. 119: 98-105. PMID 20619445 DOI: 10.1016/j.ygyno.2010.06.011 |
0.387 |
|
| 2010 |
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1675-81. PMID 20615885 DOI: 10.1158/1055-9965.Epi-10-0251 |
0.364 |
|
| 2010 |
Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer Obstetrics and Gynecology. 116: 177-185. PMID 20567185 DOI: 10.1097/Aog.0B013E3181E4629F |
0.404 |
|
| 2010 |
Arbyn M, Martin-Hirsch P, Wentzensen N. Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis. Bjog : An International Journal of Obstetrics and Gynaecology. 117: 641-4. PMID 20383875 DOI: 10.1111/j.1471-0528.2010.02521.x |
0.309 |
|
| 2010 |
Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE. Impact of improved classification on the association of human papillomavirus with cervical precancer. American Journal of Epidemiology. 171: 155-63. PMID 20007673 DOI: 10.1093/Aje/Kwp390 |
0.371 |
|
| 2009 |
Castle PE, Wentzensen N, Wheeler CM, Rydzak G, Schiffman M. Effect of the number of biopsies on the subsequent acquisition of new human papillomavirus infections. Obstetrics and Gynecology. 114: 1057-62. PMID 20168107 DOI: 10.1097/Aog.0B013E3181Bb5632 |
0.343 |
|
| 2009 |
Schiffman M, Safaeian M, Wentzensen N. The use of human papillomavirus seroepidemiology to inform vaccine policy. Sexually Transmitted Diseases. 36: 675-9. PMID 19773679 DOI: 10.1097/Olq.0B013E3181Bce102 |
0.322 |
|
| 2009 |
Wentzensen N, Zuna RE, Sherman ME, Gold MA, Schiffman M, Dunn ST, Jeronimo J, Zhang R, Walker J, Wang SS. Accuracy of cervical specimens obtained for biomarker studies in women with CIN3 Gynecologic Oncology. 115: 493-496. PMID 19773045 DOI: 10.1016/J.Ygyno.2009.09.001 |
0.341 |
|
| 2009 |
Arbyn M, Ronco G, Cuzick J, Wentzensen N, Castle PE. How to evaluate emerging technologies in cervical cancer screening? International Journal of Cancer. 125: 2489-2496. PMID 19626591 DOI: 10.1002/ijc.24774 |
0.33 |
|
| 2009 |
Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. International Journal of Cancer. Journal International Du Cancer. 125: 2151-8. PMID 19585494 DOI: 10.1002/Ijc.24528 |
0.382 |
|
| 2009 |
Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1341-9. PMID 19423515 DOI: 10.1158/1055-9965.Epi-08-1180 |
0.338 |
|
| 2009 |
Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D. The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecologic Oncology. 114: 360-4. PMID 19410282 DOI: 10.1016/J.Ygyno.2009.04.005 |
0.365 |
|
| 2009 |
Klug SJ, Wentzensen N. Cervical cancer control in the era of HPV vaccination and novel biomarkers Pathobiology. 76: 82-89. PMID 19367128 DOI: 10.1159/000201676 |
0.423 |
|
| 2009 |
Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, Schiffman M, Wacholder S, Allen RA, Block I, Downing K, Jeronimo J, Carreon JD, Safaeian M, Brown D, et al. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 113-20. PMID 19124488 DOI: 10.1158/1055-9965.Epi-08-0591 |
0.413 |
|
| 2009 |
Wentzensen N, Sherman ME, Schiffman M, Wang SS. Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science Gynecologic Oncology. 112: 293-299. PMID 19054549 DOI: 10.1016/J.Ygyno.2008.10.012 |
0.353 |
|
| 2009 |
Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, Zhang R, Sherman ME, Wacholder S, Jeronimo J, Gold MA, Wang SS. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. International Journal of Cancer. Journal International Du Cancer. 124: 964-9. PMID 19030188 DOI: 10.1002/Ijc.23969 |
0.411 |
|
| 2009 |
Wentzensen N, Gravitt PE, Solomon D, Wheeler CM, Castle PE. A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study (Cancer Epidemiology Biomarkers and Prevention (2009) 18, 1, (1341-9)) Cancer Epidemiology Biomarkers and Prevention. 18: 1943. DOI: 10.1158/1055-9965.Epi-18-6-Cor2 |
0.305 |
|
| 2008 |
Wentzensen N, Klug SJ. Early detection of cervical carcinomas: finding an overall approach. Deutsches Arzteblatt International. 105: 617-22. PMID 19471627 DOI: 10.3238/arztebl.2008.0617 |
0.439 |
|
| 2008 |
Wentzensen N, Klug SJ. Early detection of cervical carcinomas: finding an overall approach. Deutsches Arzteblatt International. 105: 617-22. PMID 19471627 DOI: 10.3238/arztebl.2008.0617 |
0.439 |
|
| 2008 |
Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz MVK, Wentzensen N. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers International Journal of Cancer. 123: 2626-2631. PMID 18785210 DOI: 10.1002/ijc.23837 |
0.362 |
|
| 2008 |
Nehls K, Vinokurova S, Schmidt D, Kommoss F, Reuschenbach M, Kisseljov F, Einenkel J, von Knebel Doeberitz M, Wentzensen N. p16 methylation does not affect protein expression in cervical carcinogenesis European Journal of Cancer. 44: 2496-2505. PMID 18722107 DOI: 10.1016/j.ejca.2008.07.014 |
0.321 |
|
| 2008 |
Gurrola-Díaz CM, Suárez-Rincón AE, Vázquez-Camacho G, Buonocunto-Vázquez G, Rosales-Quintana S, Wentzensen N, von Knebel Doeberitz M. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies Gynecologic Oncology. 111: 120-124. PMID 18692882 DOI: 10.1016/j.ygyno.2008.06.032 |
0.303 |
|
| 2008 |
Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJF, Meijer CJLM, Franceschi S, Pawlita M. Human papillomavirus infection in Ulaanbaatar, Mongolia: A population-based study Cancer Epidemiology Biomarkers and Prevention. 17: 1731-1738. PMID 18628425 DOI: 10.1158/1055-9965.EPI-07-2796 |
0.397 |
|
| 2008 |
Jeronimo J, Wentzensen N, Long R, Schiffman M, Dunn ST, Allen RA, Walker JL, Gold MA, Zuna RE, Sherman ME, Wacholder S, Wang SS. Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software. Journal of Clinical Microbiology. 46: 2759-65. PMID 18550741 DOI: 10.1128/JCM.00188-08 |
0.329 |
|
| 2008 |
Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, Kisseljov F, Dürst M, Schneider A, Doeberitz MVK. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions Cancer Research. 68: 307-313. PMID 18172324 DOI: 10.1158/0008-5472.CAN-07-2754 |
0.384 |
|
| 2008 |
Wentzensen N, Bois AD, Kommoss S, Pfisterer J, Von Knebel Doeberitz M, Schmidt D, Kommoss F. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: An analysis of the AGO Ovarian Cancer Study Group International Journal of Gynecological Pathology. 27: 18-23. PMID 18156969 DOI: 10.1097/pgp.0b013e318074b83f |
0.395 |
|
| 2007 |
Wentzensen N, Von Knebel Doeberitz M. Biomarkers in cervical cancer screening Disease Markers. 23: 315-330. PMID 17627065 |
0.436 |
|
| 2007 |
Hampl M, Wentzensen N, Vinokurova S, von Knebel-Doeberitz M, Poremba C, Bender HG, Kueppers V. Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile. Journal of Cancer Research and Clinical Oncology. 133: 235-45. PMID 17294241 DOI: 10.1007/s00432-006-0162-0 |
0.323 |
|
| 2007 |
Wentzensen N, Bergeron C, Cas F, Vinokurova S, von Knebel Doeberitz M. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia. Cancer. 111: 58-66. PMID 17186505 DOI: 10.1002/cncr.22420 |
0.366 |
|
| 2006 |
Bergeron C, Wentzensen N, Cas F, von Knebel Doeberitz M. [The p16INK4a protein: a cytological marker for detecting high grade intraepithelial neoplasia of the uterine cervix]. Annales De Pathologie. 26: 397-402. PMID 17255929 |
0.329 |
|
| 2006 |
Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstetrics and Gynecology. 108: 1361-8. PMID 17138767 DOI: 10.1097/01.AOG.0000245786.86267.80 |
0.393 |
|
| 2006 |
Wentzensen N, Hampl M, Herkert M, Reichert A, Trunk MJ, Poremba C, Ridder R, Von Knebel Doeberitz M. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples Cancer. 107: 2307-2313. PMID 17029280 DOI: 10.1002/cncr.22247 |
0.415 |
|
| 2006 |
Wentzensen N, Vinokurova S, Von Knebel Doeberitz M. Molecular markers of cervical squamous cell cancer precursor lesions Cme Journal of Gynecologic Oncology. 11: 30-40. |
0.428 |
|
| 2005 |
Vinokurova S, Wentzensen N, Einenkel J, Klaes R, Ziegert C, Melsheimer P, Sartor H, Horn LC, Höckel M, von Knebel Doeberitz M. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract Journal of the National Cancer Institute. 97: 1816-1821. PMID 16368943 DOI: 10.1093/jnci/dji428 |
0.364 |
|
| 2005 |
Vinokurova S, Wentzensen N, von Knebel Doeberitz M. Analysis of p16INK4a and integrated HPV genomes as progression markers Methods in Molecular Medicine. 119: 73-83. PMID 16350398 |
0.41 |
|
| 2005 |
Trunk MJ, Wentzensen N, Von Knebel Doeberitz M. Molecular pathogenesis of cervical cancer Pathologe. 26: 283-290. PMID 15928953 DOI: 10.1007/s00292-005-0763-4 |
0.337 |
|
| 2004 |
Wentzensen N, Vinokurova S, Von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract Cancer Research. 64: 3878-3884. PMID 15172997 DOI: 10.1158/0008-5472.CAN-04-0009 |
0.346 |
|
| 2004 |
Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, Von Knebel Doeberitz M. DNA Aneuploidy and Integration of Human Papillomavirus Type 16 E6/E7 Oncogenes in Intraepithelial Neoplasia and Invasive Squamous Cell Carcinoma of the Cervix Uteri Clinical Cancer Research. 10: 3059-3063. PMID 15131043 DOI: 10.1158/1078-0432.CCR-03-0565 |
0.317 |
|
| 2004 |
Wentzensen N, Von Knebel Doeberitz M. Viral cancerogenesis of head and neck tumors Pathologe. 25: 21-30. PMID 14767609 DOI: 10.1007/s00292-003-0669-y |
0.365 |
|
| 2003 |
Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, Von Knebel Doeberitz M. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques Oncogene. 22: 3977-3984. PMID 12813471 DOI: 10.1038/sj.onc.1206629 |
0.327 |
|
| 2003 |
Ridder R, Wentzensen N, Von Knebel Doeberitz M. Novel biomarkers for HPV associated lesions Gynakologe. 36: 323-330. |
0.331 |
|
| 2002 |
Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Von Knebel Doeberitz M. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions Oncogene. 21: 419-426. PMID 11821954 DOI: 10.1038/sj/onc/1205104 |
0.352 |
|
| 1999 |
Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, Schneider A, Lotz B, Melsheimer P, Von Knebel Doeberitz M. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes Cancer Research. 59: 6132-6136. PMID 10626803 |
0.395 |
|
| Show low-probability matches. |